World Journal of Surgical Oncology · 2020 · 67 citations · 19 references
MedicineOncologyPathologyMetastasisSignal TransductionTumor ProgressionCancer Cell SignalingEpithelial-mesenchymal TransitionEpithelial-to-mesenchymal TransitionSignal Transduction In CancerThyroid CancerTumor MarkersCell InvasionCell Invasion MechanismsEpithelial-mesenchymal Transition In CancerMesenchymal TransitionProtein Expression LevelsThyroid Cancer PathologyTumor Metastasis BiologyVimentin Expression
BACKGROUND: The purpose of this study is to explore the role and mechanism of MMP-9 in the EMT process of thyroid cancer (TC), so as to provide a basis for clinical exploration of invasion and metastasis process of TC, looking for biological markers of tumor metastasis and molecular intervention therapy. METHODS: Western blot and RT-PCR were employed to detect the expression of MMP-9 in human normal thyroid cell line HT-ori3 and human TC cell lines IHH-4 (PTC), FTC-133, and 8505C. Expression levels of EMT-related markers: epithelial cell marker E-cadherin and stromal cell marker Vimentin in TGF-1-induced TC cell lines were detected by Western blot and RT-PCR, respectively. The effects of MMP-9 downregulation on cell invasion and metastasis were investigated by wound-healing assay and cell invasion experiment. RESULTS: The protein and mRNA expression levels of MMP-9 in TC cell lines were increased compared with the human normal thyroid cell line HT-ori3. When TGF-β1 was added, the expression of EMT and Vimentin increased while the expression of E-cadherin decreased. Compared with the control group, the TC cells stably transfected with MMP-9 shRNA showed inhibited EMT, decreased Vimentin expression, and increased E-cadherin expression. The induction of TGF-β1 did not promote the occurrence of EMT in TC cells which were stably transformed with MMP-9 shRNA. The addition of TGF-β1 to TC cells increased the ability of the cells to migrate and invade. Compared with the control group, the migration and invasion ability of TC cells stably transfected with MMP-9 shRNA was significantly reduced, and the induction of TGF-β1 could not restore the migration and invasion ability of cells without MMP-9. CONCLUSIONS: In conclusion, we found that MMP-9 can be used as a biomarker for TC, which can promote the EMT process of TGF-β1 induced TC, and thus affecting the cell migration and invasion ability.
19
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2019 · 21K citations · Full text
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller, Rebecca L. Siegel, Chun Chieh Lin et al. · CA A Cancer Journal for Clinicians · 2016 · 6.2K citations · Full text
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller, Letícia Nogueira, Angela B. Mariotto et al. · CA A Cancer Journal for Clinicians · 2019 · 4.4K citations · Full text
The Increasing Incidence of Thyroid Cancer: The Influence of Access to Care
Luc G.T. Morris, Andrew G. Sikora, Tor D. Tosteson et al. · Thyroid · 2013 · 517 citations · Full text